Andrew W. Campbell, M.D.

Dr. Andrew Campbell selected as Top Medical Consultant of the Year by the International Association of Top Professionals (IAOTP)

Dr. Andrew W. Campbell, Medical Clinician, Director, Officer, Advisor, and Medical Consultant, also Editor-in Chief of several journals and research studies, was recently selected as Top Medical Consultant of the Year for 2020 by the International Association of Top Professionals (IAOTP) for his outstanding leadership, dedication and commitment to the healthcare profession.

 

Inclusion with the International Association of Top Professionals is an honor in itself, only a few members in each discipline are chosen for this distinction. These special honorees are distinguished based on their professional accomplishments, academic achievements, leadership abilities, longevity in the field, other affiliations and contributions to their communities.

 

With having over 45 years of professional experience as a renowned Medical Clinician, Dr. Campbell has certainly proven himself as an expert in the field of integrative health and traditional medicine. Dr. Campbell is a dynamic, results-driven leader who has demonstrated success by treating the most complex patients and having extensive experience with testing for molds and mycotoxins from environmental and toxic exposures. He is fluent in Arabic, Hungarian, French, Spanish and English.

 

Dr. Campbell has effectively worked alongside medical professionals from other cultures in Central and South America, Western and Eastern Europe, and the Middle East.

 

Dr. Campbell’s impressive repertoire of roles has included Medical Director at the Medical Center for Immune and Toxic Disorders, Medical Consultant for Cyrex Laboratories, Medical Advisor to Cell Systems Corp, Medical Director at The Wellness Center, Medical Advisor BCM Direct, Medical Advisor at Natural Health and Physician’s Exclusive. Currently, he serves as the Medical Director of MymycoLab, a laboratory testing mycotoxins in serum, and he is the Medical Director for Zenix Laboratory in Mexico.

Dr. Campbell’s areas of expertise include his treatment of thousands of patients with complex medical conditions from toxic exposures, specifically molds and mycotoxins, Lyme Disease, pesticides, household solvents, silicone breast implants, industrial chemicals and more. He has aided many patients with allergies, immune disorders and immune deficiencies. Dr. Campbell’s clinical interests include genomics, microbiome and neurotoxicity.

Before embarking on his professional career path, Dr. Campbell graduated from a Swiss Preparatory School at age 14 and first in his class. His next accomplishment, he completed his College studies in the United States within 3 years. Dr. Campbell obtained his Medical Degree in Mexico, then trained at the Orlando Regional Medical Center in Florida. He furthered his education at the Medical College of Georgia. Upon moving to Texas, he began serving as the Medical Director at the Medical Center for Immune and Toxic Disorders for over 20 years. Over the course of his professional career, Dr. Campbell has held various leadership positions in Hospitals all throughout the Houston area.

 

Stephanie Cirami, President of IAOTP stated, “Choosing Dr. Campbell for this honor was an easy decision for our panel to make. Dr. Campbell has tremendous foresight, extensive knowledge and is brilliant at what he does. His accomplishments are very impressive and his colleagues describe him as a great listener, who will find a solution. We are truly honored to have him as our Top Medical Consultant of the Year.”

 

Throughout his illustrious career, Dr. Campbell has received numerous awards, accolades and has been recognized worldwide for his outstanding leadership and commitment to the profession. This year he is being considered for a Front Cover feature and article in TIP (Top Industry Professionals) Magazine and will also be considered for IAOTP’s prestigious Lifetime Achievement Award. He will be honored at IAOTP’s 2020 Annual Awards Gala, being held at the magnificent Plaza Hotel in New York City for his selection as Top Medical Consultant of the Year. In past years, Dr. Campbell has been recognized as one of the Top 100 Health Professionals in Clinical Immunology and Toxicology, as an International Health Professional of the Year for his Outstanding Contributions to Clinical Toxicology and was named countless times by Marquis Who’s Who as an expert in Medicine and Healthcare, and Science and Engineering across America and throughout the World.

 

Aside from his successful career, Dr. Campbell is a sought-after lecturer and speaker, nationally and internationally at medical conferences for over 25 years and for Oxford University. He has published over 90 studies of his findings in peer-reviewed medical journals and medical textbook chapters. Dr. Campbell has also served as Editor-in- Chief, Co-Editor, Associate Editor and on the Editorial Board of several Medical Journals including Integrative Medicine, A Clinician’s Journal, International Journal for Complimentary and Alternative Medicine, Research in Medical and Engineering Sciences, Biomedical Journal of Scientific and Technical Research, Advances in Mind- Body Medicine and Alternative Therapies in Health and Medicine.

 

As a highly regarded medical consultant, Dr. Campbell has become well-known and been featured on a number of television shows which include 20/20, the Montel Williams Show, and 24-Hour Investigative News. He has been interviewed by ABC, CBS and NBC and its affiliates throughout the United States and can be viewed on several television programs in both Canada and Mexico.

 

Being an active member within his community for many years, Dr. Campbell is a Founder and also the Medical Director at the St. Vianney Clinic for the Indigent. He is experienced in obtaining licenses and import permits for medical supplements and medical equipment into Mexico and Latin American Countries. In the United States, he lends his expertise in medical management and clinical program developments and also in several foreign countries. He has conducted a number of clinical trials as the principle investigator for supplement companies in the U.S. and he is conducting these in other countries to reduce costs.

 

Looking back, Dr. Campbell attributes his success to his hard work ethic, his love for education and science, and to every skillful medical professional he has had the honor of working alongside throughout his entire career. When not working, he enjoys traveling and spending time with his family. For the future, he hopes to continue making breakthroughs in medicine and helping his patients achieve optimal health.

 

Here is a list of Dr. Campbell’s studies on Molds and Mycotoxins published in various peer-reviewed medical journals.  These can also be found in the United States Library of Medicine, aka PubMed.gov.  

1. Campbell, AW. Lyme Disease and Mycotoxicosis: How to Differentiate Between the Two. Altern Ther Health Med. 2019 Jul;25(4):8-10.

 

1. Lieberman A, Curtis L, Campbell AW. Development of New-Onset Chronic Inflammatory Demyelinating Polyneuropathy Following Exposure to a Water-Damaged Home With High Airborne Mold Levels: A Report of Two Cases and a Review of the Literature. J Neurol Res. 2017;7(3):59-62.

 

1. Campbell, AW. Molds and Mycotoxins: A Brief Review. Altern Ther Health Med. 2016; 22(3):8-11.

 

1. Campbell AW.: Molds and Mycotoxins. Altern Ther Health Med, 18(1), 8-10, January 2012.

 

1. Brasel TL., Campbell AW., Demers RE., Ferguson BS.,  Fink J., Vojdani A., Wilson SC., Straus DC.: Detection of Trichothecene Mycotoxins in Sera from Individuals Exposed to Stachybotrys Chartarum in Indoor Environments. Arch Environ Health, 59(6), 317-323, June 2004.

 

1. Campbell AW.; Thrasher JD.; Gray MR.; Vojdani A.: Chapter: “Mold and Mycotoxins: Effects on the Neurological and Immune Systems in Humans.” Adv Appl Microbiol (Volume 55). David C. Straus., (ed.), Published by Elsevier Inc., 2004.

 

1. Gray MR.., Thrasher JD., Crago R., Madison RA., Arnold L., Campbell AW., Vojdani A: Chapter: “Mixed Mold Mycotoxicosis: Immunological Changes in Humans Following Exposure in Water-Damaged Buildings.” Molds and Mycotoxins.* Kaye H. Kilburn, M.D. (ed.), Published by Heldref Publications, 2004.

 

1. Campbell AW., Thrasher JD., Madison RA., Vojdani A., Gray MR., Arnold L.: Chapter: “Neural Autoantibodies and Neurophysiologic Abnormalities in Patients Exposed to Molds in Water-Damaged Buildings.” Molds and Mycotoxins. Kaye H. Kilburn, M.D. (ed.), Published by Heldref Publications, 2004.

 

1. Vojdani A., Thrasher JD., Madison RA., Gray MR.,   Heuser G., Campbell AW., Chapter: “Antibodies to Molds and Satratoxin in Individuals Exposed in Water-Damaged Buildings.” Molds and Mycotoxins. Kaye H. Kilburn, M.D. (ed.), Published by Heldref Publications, 2004.

 

1. Campbell AW., Anyanwu EC., Mohammed M.: Evaluation of the Drug Treatment and Persistence of Onychomycosis. ScientificWorldJournal, 4:760-777, 2004.

 

1. Anyanwu EC., Mohammed M., Campbell AW: Metabolism of Mycotoxins, Intracellular Functions of Vitamin B12, and Neurological Manifestations in Patients with Chronic Toxigenic Mold Exposures. A Review. ScientificWorldJournal, 4:736-745, 2004.

 

1. Anyanwu EC., Campbell AW., Ehiri JE: Mycotoxins and Antifungal Drug Interactions: Implications in the Treatment of Illnesses Due to Indoor Chronic Toxigenic Mold Exposures. ScientificWorldJournal, 4:167-177, 2004.

 

1. Campbell AW., Thrasher JD., Madison RA., Vojdani A., Gray MR., Johnson AL.: Neural Autoantibodies and Neurophysiologic Abnormalities in Patients Exposed to Molds in Water-Damaged Buildings. Arch Environ Health, 58(8), 464-474, August 2003.

 

1. Vojdani A., Thrasher JD., Madison RA., Gray MR., Heuser G., Campbell AW: Antibodies to Molds and Satratoxin in Individuals Exposed in Water-Damaged Buildings. Arch Environ Health, 58(7), 421-432, July 2003.

 

1. Anyanwu E., Campbell AW., Vojdani A., Ehiri JE, Akpan Al: Biochemical Changes in the Serum of Patients with Chronic Toxigenic Mold Exposures: A Risk Factor for Multiple Renal Dysfunctions. Scientific World Journal, 3(11), 1058-1064, Nov. 3, 2003.  

 

1. Anyanwu E., Campbell A., Jones J., Ehiri J: The Neurological Significance of Abnormal Natural Killer Cell Activity in Chronic Toxigenic Mold Exposures. Scientific World Journal, 3:1128-1137, 2003.

 

1. Campbell A, Anyanwu E, Vojdani A: Combination of High-dose Intravenous Immunoglobulins and Itraconazole in Treating Chronic Mycotic Demyelinating Optic Neuritis. Scientific World Journal, 3:640-646, 2003.

 

1. Anyanwu E, Campbell A, Vojdani A: Neurophysiological Effects of Chronic Indoor Environmental Toxic Mold Exposure on Children. Scientific World Journal, 3:281-290, April 28, 2003.

 

1. Vojdani A, Campbell A, Kashanian A, Vojdani E: Saliva Secretory IgA Antibodies Against Molds and Mycotoxins in Patients Exposed to Toxigenic Fungi. Immunopharmacol Immunotoxicol, Vol 25(4): 595-614, 2003.

 

1. Anyanwu, E.; Campbell, A.; Vojdani, A.: Brainstem Auditory Evoked Response in Adolescents with Acoustic Mycotic Neuroma Due to Environmental Exposure to Toxic Molds. Int J Adolesc Med Health, March 2002.